Rheumatology and therapy

Keyphrases

Publications

volume 11, number 3, 2024

Andri Phoka, Bartholomeus J F van den Bemt, Ennio Lubrano, Inderjit Singh, Cristina Fernández-Carballido, Detlev Parow, Dale Webb, Fabienne Lacombe, Laura Harrington, Xenofon Baraliakos
Elevating the Standard of Care for Patients with Axial Spondyloarthritis: 'Calls to Action' from Rheumacensus, a Multistakeholder Pan-European Initiative. Rheumatology and therapy 11 (3) (2024)
Lyrialle W Han, Samira Jamalian, Joy C Hsu, X Rebecca Sheng, Xiaoyun Yang, Xiaoying Yang, Sharareh Monemi, Sharmeen Hassan, Rajbharan Yadav, Katie Tuckwell, Rebecca Kunder, Lin Pan, Sara Glickstein
A Phase 1a Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7303509, an Anti-TGFβ3 Antibody, in Healthy Volunteers. Rheumatology and therapy 11 (3) (2024)

volume 11, number 4, 2024

Jiale Xie, Xin Xu, Mingyi Yang, Hui Yu, Jinrong Hao, Dinglong Yang, Peng Xu
New Insights on the Therapeutic Potential of Runt-Related Transcription Factor 2 for Osteoarthritis: Evidence from Mendelian Randomization. Rheumatology and therapy 11 (4) (2024)
Bernard Rubin, Yan Chen, Karen Worley, Brendan Rabideau, Benson Wu, Rose Chang, Maral DerSarkissian
Improved Health Outcomes in Patients with Systemic Lupus Erythematosus Following Early Belimumab Initiation Without Prior Immunosuppressant Use: A Real-World Descriptive Study. Rheumatology and therapy 11 (4) (2024)
Xenofon Baraliakos, Christopher D Saffore, Eric B Collins, Bhumik Parikh, Xiaolan Ye, Jessica A Walsh
Comparative Efficacy of Advanced Therapies in the Treatment of Radiographic Axial Spondyloarthritis or Ankylosing Spondylitis as Evaluated by the ASDAS Low Disease Activity Criteria. Rheumatology and therapy 11 (4) (2024)
Abdulla Watad, Alen Zabotti, Yonatan Shneor Patt, Omer Gendelman, Arad Dotan, Niv Ben-Shabat, Lior Fisher, Dennis McGonagle, Howard Amital
From Psoriasis to Psoriatic Arthritis: Decoding the Impact of Treatment Modalities on the Prevention of Psoriatic Arthritis. Rheumatology and therapy 11 (4) (2024)
Xenofon Baraliakos, Christopher D Saffore, Eric B Collins, Bhumik Parikh, Xiaolan Ye, Jessica A Walsh
Comparative Efficacy of Advanced Therapies in the Treatment of Radiographic Axial Spondyloarthritis or Ankylosing Spondylitis as Evaluated by the ASDAS Low Disease Activity Criteria. Rheumatology and therapy 11 (4) (2024)
Walter P Maksymowych, Howard Thom, Michael F Mørup, Vanessa Taieb, Damon Willems, Nikos Lyris, Karl Gaffney
Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis. Rheumatology and therapy 11 (4) (2024)
Min Wook So, A-Ran Kim, Seung-Geun Lee
Drug Persistence and Incidence of Active Tuberculosis of Tumor Necrosis Factor Alpha Inhibitors Versus Tocilizumab as the First-Line Biological Treatment in Patients with Rheumatoid Arthritis: A Nationwide Population-Based Retrospective Cohort Analysis. Rheumatology and therapy 11 (4) (2024)
Melda Bahap-Kara, Emine Duran, Gözde Kübra Yardimci, Ömer Karadağ, Aygin Bayraktar Ekincioğlu
Addressing Glucocorticoid-Related Problems with the Clinical Pharmacist Collaboration in Rheumatology Practice: A Prospective Follow-Up Study. Rheumatology and therapy 11 (4) (2024)
Walter P Maksymowych, Howard Thom, Michael F Mørup, Vanessa Taieb, Damon Willems, Nikos Lyris, Karl Gaffney
Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis. Rheumatology and therapy 11 (4) (2024)
Xiaoxia Zhu, Jiankang Hu, Dongzhou Liu, Jingyang Li, Huaxiang Wu, Lingyun Sun, Lie Dai, Chunyu Tan, Zhijun Li, Zhengyu Xiao, Xiaomei Li, Yan Yan, Guanshen Dou, Yuzi Sun, Hejian Zou
Rapid and Sustained Effect of Ixekizumab on Patient Global, Spinal Pain, Stiffness, and Fatigue in Chinese Patients with Radiographic Axial Spondyloarthritis. Rheumatology and therapy 11 (4) (2024)
Zhen-Wei Shen, Kai-Qi Wu, Ting-Han Jin, Jie Zhao, Qi Jiang, Tong Guo, Min Fang, Gui-Ling Chen
Pharmacokinetics, Safety, and Immunogenicity of Intravenous and Subcutaneous Single-Dose QX002N Injection in Healthy Subjects: A Randomized, Open, Parallel, Single-Center, Phase I Study. Rheumatology and therapy 11 (4) (2024)
Abdulla Watad, Alen Zabotti, Yonatan Shneor Patt, Omer Gendelman, Arad Dotan, Niv Ben-Shabat, Lior Fisher, Dennis McGonagle, Howard Amital
From Psoriasis to Psoriatic Arthritis: Decoding the Impact of Treatment Modalities on the Prevention of Psoriatic Arthritis. Rheumatology and therapy 11 (4) (2024)
Bernard Rubin, Yan Chen, Karen Worley, Brendan Rabideau, Benson Wu, Rose Chang, Maral DerSarkissian
Improved Health Outcomes in Patients with Systemic Lupus Erythematosus Following Early Belimumab Initiation Without Prior Immunosuppressant Use: A Real-World Descriptive Study. Rheumatology and therapy 11 (4) (2024)
Melda Bahap-Kara, Emine Duran, Gözde Kübra Yardimci, Ömer Karadağ, Aygin Bayraktar Ekincioğlu
Addressing Glucocorticoid-Related Problems with the Clinical Pharmacist Collaboration in Rheumatology Practice: A Prospective Follow-Up Study. Rheumatology and therapy 11 (4) (2024)
Joshua Card-Gowers, Lise Retat, Ada Kumar, Brad A Marder, Lissa Padnick-Silver, Brian LaMoreaux, Laura Webber
Projected Health and Economic Burden of Comorbid Gout and Chronic Kidney Disease in a Virtual US Population: A Microsimulation Study. Rheumatology and therapy 11 (4) (2024)
Abdulla Watad, Alen Zabotti, Yonatan Shneor Patt, Omer Gendelman, Arad Dotan, Niv Ben-Shabat, Lior Fisher, Dennis McGonagle, Howard Amital
From Psoriasis to Psoriatic Arthritis: Decoding the Impact of Treatment Modalities on the Prevention of Psoriatic Arthritis. Rheumatology and therapy 11 (4) (2024)
Joshua Card-Gowers, Lise Retat, Ada Kumar, Brad A Marder, Lissa Padnick-Silver, Brian LaMoreaux, Laura Webber
Projected Health and Economic Burden of Comorbid Gout and Chronic Kidney Disease in a Virtual US Population: A Microsimulation Study. Rheumatology and therapy 11 (4) (2024)
Jiale Xie, Xin Xu, Mingyi Yang, Hui Yu, Jinrong Hao, Dinglong Yang, Peng Xu
New Insights on the Therapeutic Potential of Runt-Related Transcription Factor 2 for Osteoarthritis: Evidence from Mendelian Randomization. Rheumatology and therapy 11 (4) (2024)
Xenofon Baraliakos, Christopher D Saffore, Eric B Collins, Bhumik Parikh, Xiaolan Ye, Jessica A Walsh
Comparative Efficacy of Advanced Therapies in the Treatment of Radiographic Axial Spondyloarthritis or Ankylosing Spondylitis as Evaluated by the ASDAS Low Disease Activity Criteria. Rheumatology and therapy 11 (4) (2024)
Melda Bahap-Kara, Emine Duran, Gözde Kübra Yardimci, Ömer Karadağ, Aygin Bayraktar Ekincioğlu
Addressing Glucocorticoid-Related Problems with the Clinical Pharmacist Collaboration in Rheumatology Practice: A Prospective Follow-Up Study. Rheumatology and therapy 11 (4) (2024)
Joshua Card-Gowers, Lise Retat, Ada Kumar, Brad A Marder, Lissa Padnick-Silver, Brian LaMoreaux, Laura Webber
Projected Health and Economic Burden of Comorbid Gout and Chronic Kidney Disease in a Virtual US Population: A Microsimulation Study. Rheumatology and therapy 11 (4) (2024)
Jiale Xie, Xin Xu, Mingyi Yang, Hui Yu, Jinrong Hao, Dinglong Yang, Peng Xu
New Insights on the Therapeutic Potential of Runt-Related Transcription Factor 2 for Osteoarthritis: Evidence from Mendelian Randomization. Rheumatology and therapy 11 (4) (2024)
Marco Garrido-Cumbrera, Denis Poddubnyy, Fernando Sommerfleck, Christine Bundy, Souzi Makri, José Correa-Fernández, Shashank Akerkar, Jo Lowe, Elie G Karam, Victoria Navarro-Compán
Regional Differences in Diagnosis Journey and Healthcare Utilization: Results from the International Map of Axial Spondyloarthritis (IMAS). Rheumatology and therapy 11 (4) (2024)
Marco Garrido-Cumbrera, Denis Poddubnyy, Fernando Sommerfleck, Christine Bundy, Souzi Makri, José Correa-Fernández, Shashank Akerkar, Jo Lowe, Elie G Karam, Victoria Navarro-Compán
Regional Differences in Diagnosis Journey and Healthcare Utilization: Results from the International Map of Axial Spondyloarthritis (IMAS). Rheumatology and therapy 11 (4) (2024)
Bernard Rubin, Yan Chen, Karen Worley, Brendan Rabideau, Benson Wu, Rose Chang, Maral DerSarkissian
Improved Health Outcomes in Patients with Systemic Lupus Erythematosus Following Early Belimumab Initiation Without Prior Immunosuppressant Use: A Real-World Descriptive Study. Rheumatology and therapy 11 (4) (2024)
Xenofon Baraliakos, Christopher D Saffore, Eric B Collins, Bhumik Parikh, Xiaolan Ye, Jessica A Walsh
Comparative Efficacy of Advanced Therapies in the Treatment of Radiographic Axial Spondyloarthritis or Ankylosing Spondylitis as Evaluated by the ASDAS Low Disease Activity Criteria. Rheumatology and therapy 11 (4) (2024)
Konstantinos Triantafyllias, Stefanie Liverakos, Muthuraman Muthuraman, Lorenzo Cavagna, Ioannis Parodis, Andreas Schwarting
Cardiovascular Risk Evaluation in Psoriatic Arthritis by Aortic Stiffness and the Systemic Coronary Risk Evaluation (SCORE): Results of the Prospective PSOCARD Cohort Study. Rheumatology and therapy 11 (4) (2024)
Jiale Xie, Xin Xu, Mingyi Yang, Hui Yu, Jinrong Hao, Dinglong Yang, Peng Xu
New Insights on the Therapeutic Potential of Runt-Related Transcription Factor 2 for Osteoarthritis: Evidence from Mendelian Randomization. Rheumatology and therapy 11 (4) (2024)
Marco Garrido-Cumbrera, Denis Poddubnyy, Fernando Sommerfleck, Christine Bundy, Souzi Makri, José Correa-Fernández, Shashank Akerkar, Jo Lowe, Elie G Karam, Victoria Navarro-Compán
Regional Differences in Diagnosis Journey and Healthcare Utilization: Results from the International Map of Axial Spondyloarthritis (IMAS). Rheumatology and therapy 11 (4) (2024)
Xiaoxia Zhu, Jiankang Hu, Dongzhou Liu, Jingyang Li, Huaxiang Wu, Lingyun Sun, Lie Dai, Chunyu Tan, Zhijun Li, Zhengyu Xiao, Xiaomei Li, Yan Yan, Guanshen Dou, Yuzi Sun, Hejian Zou
Rapid and Sustained Effect of Ixekizumab on Patient Global, Spinal Pain, Stiffness, and Fatigue in Chinese Patients with Radiographic Axial Spondyloarthritis. Rheumatology and therapy 11 (4) (2024)
Min Wook So, A-Ran Kim, Seung-Geun Lee
Drug Persistence and Incidence of Active Tuberculosis of Tumor Necrosis Factor Alpha Inhibitors Versus Tocilizumab as the First-Line Biological Treatment in Patients with Rheumatoid Arthritis: A Nationwide Population-Based Retrospective Cohort Analysis. Rheumatology and therapy 11 (4) (2024)
Konstantinos Triantafyllias, Stefanie Liverakos, Muthuraman Muthuraman, Lorenzo Cavagna, Ioannis Parodis, Andreas Schwarting
Cardiovascular Risk Evaluation in Psoriatic Arthritis by Aortic Stiffness and the Systemic Coronary Risk Evaluation (SCORE): Results of the Prospective PSOCARD Cohort Study. Rheumatology and therapy 11 (4) (2024)
Xiaoxia Zhu, Jiankang Hu, Dongzhou Liu, Jingyang Li, Huaxiang Wu, Lingyun Sun, Lie Dai, Chunyu Tan, Zhijun Li, Zhengyu Xiao, Xiaomei Li, Yan Yan, Guanshen Dou, Yuzi Sun, Hejian Zou
Rapid and Sustained Effect of Ixekizumab on Patient Global, Spinal Pain, Stiffness, and Fatigue in Chinese Patients with Radiographic Axial Spondyloarthritis. Rheumatology and therapy 11 (4) (2024)
Walter P Maksymowych, Howard Thom, Michael F Mørup, Vanessa Taieb, Damon Willems, Nikos Lyris, Karl Gaffney
Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis. Rheumatology and therapy 11 (4) (2024)
Marco Garrido-Cumbrera, Denis Poddubnyy, Fernando Sommerfleck, Christine Bundy, Souzi Makri, José Correa-Fernández, Shashank Akerkar, Jo Lowe, Elie G Karam, Victoria Navarro-Compán
Regional Differences in Diagnosis Journey and Healthcare Utilization: Results from the International Map of Axial Spondyloarthritis (IMAS). Rheumatology and therapy 11 (4) (2024)
Bernard Rubin, Yan Chen, Karen Worley, Brendan Rabideau, Benson Wu, Rose Chang, Maral DerSarkissian
Improved Health Outcomes in Patients with Systemic Lupus Erythematosus Following Early Belimumab Initiation Without Prior Immunosuppressant Use: A Real-World Descriptive Study. Rheumatology and therapy 11 (4) (2024)
Konstantinos Triantafyllias, Stefanie Liverakos, Muthuraman Muthuraman, Lorenzo Cavagna, Ioannis Parodis, Andreas Schwarting
Cardiovascular Risk Evaluation in Psoriatic Arthritis by Aortic Stiffness and the Systemic Coronary Risk Evaluation (SCORE): Results of the Prospective PSOCARD Cohort Study. Rheumatology and therapy 11 (4) (2024)
Zhen-Wei Shen, Kai-Qi Wu, Ting-Han Jin, Jie Zhao, Qi Jiang, Tong Guo, Min Fang, Gui-Ling Chen
Pharmacokinetics, Safety, and Immunogenicity of Intravenous and Subcutaneous Single-Dose QX002N Injection in Healthy Subjects: A Randomized, Open, Parallel, Single-Center, Phase I Study. Rheumatology and therapy 11 (4) (2024)
Xiaoxia Zhu, Jiankang Hu, Dongzhou Liu, Jingyang Li, Huaxiang Wu, Lingyun Sun, Lie Dai, Chunyu Tan, Zhijun Li, Zhengyu Xiao, Xiaomei Li, Yan Yan, Guanshen Dou, Yuzi Sun, Hejian Zou
Rapid and Sustained Effect of Ixekizumab on Patient Global, Spinal Pain, Stiffness, and Fatigue in Chinese Patients with Radiographic Axial Spondyloarthritis. Rheumatology and therapy 11 (4) (2024)
Walter P Maksymowych, Howard Thom, Michael F Mørup, Vanessa Taieb, Damon Willems, Nikos Lyris, Karl Gaffney
Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis. Rheumatology and therapy 11 (4) (2024)
Zhen-Wei Shen, Kai-Qi Wu, Ting-Han Jin, Jie Zhao, Qi Jiang, Tong Guo, Min Fang, Gui-Ling Chen
Pharmacokinetics, Safety, and Immunogenicity of Intravenous and Subcutaneous Single-Dose QX002N Injection in Healthy Subjects: A Randomized, Open, Parallel, Single-Center, Phase I Study. Rheumatology and therapy 11 (4) (2024)
Melda Bahap-Kara, Emine Duran, Gözde Kübra Yardimci, Ömer Karadağ, Aygin Bayraktar Ekincioğlu
Addressing Glucocorticoid-Related Problems with the Clinical Pharmacist Collaboration in Rheumatology Practice: A Prospective Follow-Up Study. Rheumatology and therapy 11 (4) (2024)
Min Wook So, A-Ran Kim, Seung-Geun Lee
Drug Persistence and Incidence of Active Tuberculosis of Tumor Necrosis Factor Alpha Inhibitors Versus Tocilizumab as the First-Line Biological Treatment in Patients with Rheumatoid Arthritis: A Nationwide Population-Based Retrospective Cohort Analysis. Rheumatology and therapy 11 (4) (2024)
Konstantinos Triantafyllias, Stefanie Liverakos, Muthuraman Muthuraman, Lorenzo Cavagna, Ioannis Parodis, Andreas Schwarting
Cardiovascular Risk Evaluation in Psoriatic Arthritis by Aortic Stiffness and the Systemic Coronary Risk Evaluation (SCORE): Results of the Prospective PSOCARD Cohort Study. Rheumatology and therapy 11 (4) (2024)
Abdulla Watad, Alen Zabotti, Yonatan Shneor Patt, Omer Gendelman, Arad Dotan, Niv Ben-Shabat, Lior Fisher, Dennis McGonagle, Howard Amital
From Psoriasis to Psoriatic Arthritis: Decoding the Impact of Treatment Modalities on the Prevention of Psoriatic Arthritis. Rheumatology and therapy 11 (4) (2024)
Zhen-Wei Shen, Kai-Qi Wu, Ting-Han Jin, Jie Zhao, Qi Jiang, Tong Guo, Min Fang, Gui-Ling Chen
Pharmacokinetics, Safety, and Immunogenicity of Intravenous and Subcutaneous Single-Dose QX002N Injection in Healthy Subjects: A Randomized, Open, Parallel, Single-Center, Phase I Study. Rheumatology and therapy 11 (4) (2024)
Joshua Card-Gowers, Lise Retat, Ada Kumar, Brad A Marder, Lissa Padnick-Silver, Brian LaMoreaux, Laura Webber
Projected Health and Economic Burden of Comorbid Gout and Chronic Kidney Disease in a Virtual US Population: A Microsimulation Study. Rheumatology and therapy 11 (4) (2024)
Min Wook So, A-Ran Kim, Seung-Geun Lee
Drug Persistence and Incidence of Active Tuberculosis of Tumor Necrosis Factor Alpha Inhibitors Versus Tocilizumab as the First-Line Biological Treatment in Patients with Rheumatoid Arthritis: A Nationwide Population-Based Retrospective Cohort Analysis. Rheumatology and therapy 11 (4) (2024)